Shopping Cart 0
Cart Subtotal
AED 0

Global Critical Care diagnostics Market Size study, by Type (Flow cytometry, Immunoproteins, Routine and special chemistry, Hematology, Coagulation test, Microbial and infectious diseases and others) End-user (Intensive care units, Emergency rooms, Operating rooms and others) and Regional Forecasts 2018-2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 14497

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 20369

Details

Global Critical Care diagnostics Market to reach USD 1.4 billion by 2025.
 
Global Critical Care diagnostics Market valued approximately USD 0.9 billion in 2017 is anticipated to grow with a healthy growth rate of more than 6.0 % over the forecast period 2018-2025. Rising acceptance of these tests by patients and physicians and improvements in healthcare technologies are some factors triggering the growth of the critical care diagnostics market over the forecast period.
Key driving factors for the critical care diagnostics market are high prevalence of chronic diseases along with the technological advancements in critical care diagnostics products. For instance: According to British Heart Foundation, more than one fourth of the deaths in UK are due to CVD, accounting around 3.9 million deaths each year. There are 7 million people living with CVD in the U.K. Also, coronary heart diseases are the leading cause for deaths in U.K. and nearly one in six men and one in ten women die from coronary heart disease. CHD is responsible for around 73,000 deaths in the UK each year. In UK, CHD affects the aging population and around 23,000 people under the age of 75 die from CHD each year. In addition, the Fight Chronic Disease Organization estimates that in 2015, in United States around 133 million deaths are caused and disability due to chronic diseases. It is estimated that 45% Americans populations are suffering from at least one chronic disease. Since, critical care diagnostics tests allows clinicians to identify and detect organism accurately and helps to offer proper guidance to clinicians thereby, promoting the demand for critical care diagnostics tests over the forecast period. Furthermore, growing adoption of electronic health record (EHR) coupled with the telehealth services is offers lucrative growth prospects for the critical care diagnostics market. However, high cost associated with molecular diagnostics tools are expected to hinder the growth of the market during the forecast period.
On the basis of segmentation, the critical care diagnostics market is segmented into type and end-user. The type segment of global critical care diagnostics market is classified into flow cytometry, immunoproteins, routine and special chemistry, hematology, coagulation test, microbial and infectious diseases and others of which immunoproteins diagnostic test is also to dominate the market with largest share due to growing demand for accurate preventive healthcare services. On the basis of end-user segment, the market is classified into intensive care units, emergency rooms, operating rooms and others of which emergency rooms are anticipated to witness lucrative growth owing to the growing need for ER service as it offers initial acute care treatment and diagnosis to critically ill patients.
 
The regional analysis of critical care diagnostics market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in critical care diagnostics market owing to the high research and development activities along with presence of well-established healthcare infrastructure. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to high prevalence of chronic diseases along with rising geriatric population. Also, improving healthcare infrastructure and services in rural areas is also expected to supplement the growth of Asia-Pacific region over the forecast period.
The leading market players include-
 
Abbott Laboratories
Alere, Inc.
Beckman Coulter, Inc.
Becton Dickinson and Company,
Bayer AG
Siemens Healthineers
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories
BioMerieux, Inc.
Nova Biomedical
 
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Flow Cytometry
Microbial and Infectious Diseases
Routine and special chemistry
Hematology
Immunoproteins
Coagulation Test
Others
By End-user:
Emergency rooms
Intensive Care Units
Operating Rooms
Other End Users
 
By Regions:
North America
o U.S.
o Canada
Europe
o UK
o Germany
o ROE
Asia Pacific
o China
o India
o Japan
o ROAPEC
LAMEA
o Brazil
o Mexico
ROW
o Middle East & Africa
 
Furthermore, years considered for the study are as follows:
 
Historical year - 2015, 2016
Base year - 2017
Forecast period - 2018 to 2025
 
Target Audience of the Global Critical Care diagnostics Market in Market Study:
 
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
READ MORE

Table Of Content

Scope

TABLE OF CONTENTS

Chapter 1. Global Critical Care diagnostics Market Definition and Scope

1.1. Research Objective

1.2. Market Definition

1.3. Scope of The Study

1.4. Years Considered for The Study

1.5. Currency Conversion Rates

1.6. Report Limitation

Chapter 2. Research Methodology

2.1. Research Process

2.1.1. Data Mining

2.1.2. Analysis

2.1.3. Market Estimation

2.1.4. Validation

2.1.5. Publishing

2.2. Research Assumption

Chapter 3. Executive Summary

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2. Key Trends

Chapter 4. Global Critical Care diagnostics Market Dynamics

4.1. Growth Prospects

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.2. Industry Analysis

4.2.1. Porter's 5 Force Model

4.2.2. PEST Analysis

4.2.3. Value Chain Analysis

4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Critical Care diagnostics Market, By Type

5.1. Market Snapshot

5.2. Market Performance - Potential Model

5.3. Global Critical Care diagnostics Market, Sub Segment Analysis

5.3.1. Flow Cytometry

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2. Hematology

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.3. Routine and special chemistry

5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.4. Microbial and infectious diseases

5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.5. Immunoproteins

5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.6. Coagulation test

5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.7. Others

5.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Critical Care diagnostics Market, By End-user

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Global Critical Care diagnostics Market, Sub Segment Analysis

6.3.1. Emergency Rooms

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2. Operating rooms

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3. Intensive care units

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4. Other End-users

6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Critical Care diagnostics Market, by Regional Analysis

7.1. Critical Care diagnostics Market, Regional Market Snapshot (2015-2025)

7.2. North America Critical Care diagnostics Market Snapshot

7.2.1. U.S.

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2. Canada

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3. Europe Critical Care diagnostics Market Snapshot

7.3.1. U.K.

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

7.3.2. Germany

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3. Rest of Europe

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4. Asia Critical Care diagnostics Market Snapshot

7.4.1. China

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2. India

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3. Japan

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4. Rest of Asia Pacific

7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

7.5. Latin America Critical Care diagnostics Market Snapshot

7.5.1. Brazil

7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

7.5.2. Mexico

7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6. Rest of The World

7.6.1. Middle East and Africa

7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

Chapter 8. Competitive Intelligence

8.1. Company Market Share (Subject to Data Availability)

8.2. Top Market Strategies

8.3. Company Profiles

8.3.1. Abbott Laboratories

8.3.1.1. Overview

8.3.1.2. Financial (Subject to Data Availability)

8.3.1.3. Product Summary

8.3.1.4. Recent Developments

8.3.2. Alere, Inc.

8.3.3. Beckman Coulter, Inc.

8.3.4. Becton Dickinson and Company,

8.3.5. Bayer AG

8.3.6. Siemens Healthineers

8.3.7. F. Hoffmann-La Roche Ltd.

8.3.8. Bio-Rad Laboratories

8.3.9. BioMerieux, Inc.

8.3.10. Nova Biomedical


List Of Figure

FIG 1. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY

FIG 2. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES

FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS

FIG 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, KEY TRENDS 2016

FIG 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2017-2025

FIG 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL

FIG 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, PEST ANALYSIS

FIG 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS

FIG 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 15. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 16. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 17. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 18. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 19. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 20. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2015 & 2025

FIG 21. NORTH AMERICA CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 22. EUROPE CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 23. ASIA PACIFIC CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 24. LATIN AMERICA CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 25. ROW CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 26. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)


List Of Table

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CRITICAL CARE DIAGNOSTICS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CRITICAL CARE DIAGNOSTICS MARKET

TABLE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)

TABLE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)

TABLE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2015-2025 (USD BILLION)

TABLE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 15. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 16. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 17. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 18. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 19. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 20. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 21. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 22. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 23. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 24. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 25. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 26. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 27. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 28. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 29. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 30. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 31. U.S. CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 32. U.S CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 33. U.S CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 34. CANADA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 35. CANADA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 36. CANADA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 37. UK CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 38. UK CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 39. UK CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 40. GERMANY CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 41. GERMANY CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 42. GERMANY CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 43. ROE CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 44. ROE CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 45. ROE CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 46. CHINA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 47. CHINA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 48. CHINA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 49. INDIA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 50. INDIA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 51. INDIA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 52. JAPAN CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 53. JAPAN CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 54. JAPAN CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 55. ROAPAC CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 56. ROAPAC CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 57. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 58. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 59. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 60. MEXICO CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 61. MEXICO CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 62. MEXICO CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 63. MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 64. MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 65. MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Abbott Laboratories

Alere, Inc.

Beckman Coulter, Inc.

Becton Dickinson and Company,

Bayer AG

Siemens Healthineers

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories

BioMerieux, Inc.

Nova Biomedical

Company Profile

Company Profile Title

Global Critical Care diagnostics Market to reach USD 1.4 billion by 2025.
 
Global Critical Care diagnostics Market valued approximately USD 0.9 billion in 2017 is anticipated to grow with a healthy growth rate of more than 6.0 % over the forecast period 2018-2025. Rising acceptance of these tests by patients and physicians and improvements in healthcare technologies are some factors triggering the growth of the critical care diagnostics market over the forecast period.
Key driving factors for the critical care diagnostics market are high prevalence of chronic diseases along with the technological advancements in critical care diagnostics products. For instance: According to British Heart Foundation, more than one fourth of the deaths in UK are due to CVD, accounting around 3.9 million deaths each year. There are 7 million people living with CVD in the U.K. Also, coronary heart diseases are the leading cause for deaths in U.K. and nearly one in six men and one in ten women die from coronary heart disease. CHD is responsible for around 73,000 deaths in the UK each year. In UK, CHD affects the aging population and around 23,000 people under the age of 75 die from CHD each year. In addition, the Fight Chronic Disease Organization estimates that in 2015, in United States around 133 million deaths are caused and disability due to chronic diseases. It is estimated that 45% Americans populations are suffering from at least one chronic disease. Since, critical care diagnostics tests allows clinicians to identify and detect organism accurately and helps to offer proper guidance to clinicians thereby, promoting the demand for critical care diagnostics tests over the forecast period. Furthermore, growing adoption of electronic health record (EHR) coupled with the telehealth services is offers lucrative growth prospects for the critical care diagnostics market. However, high cost associated with molecular diagnostics tools are expected to hinder the growth of the market during the forecast period.
On the basis of segmentation, the critical care diagnostics market is segmented into type and end-user. The type segment of global critical care diagnostics market is classified into flow cytometry, immunoproteins, routine and special chemistry, hematology, coagulation test, microbial and infectious diseases and others of which immunoproteins diagnostic test is also to dominate the market with largest share due to growing demand for accurate preventive healthcare services. On the basis of end-user segment, the market is classified into intensive care units, emergency rooms, operating rooms and others of which emergency rooms are anticipated to witness lucrative growth owing to the growing need for ER service as it offers initial acute care treatment and diagnosis to critically ill patients.
 
The regional analysis of critical care diagnostics market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in critical care diagnostics market owing to the high research and development activities along with presence of well-established healthcare infrastructure. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to high prevalence of chronic diseases along with rising geriatric population. Also, improving healthcare infrastructure and services in rural areas is also expected to supplement the growth of Asia-Pacific region over the forecast period.
The leading market players include-
 
Abbott Laboratories
Alere, Inc.
Beckman Coulter, Inc.
Becton Dickinson and Company,
Bayer AG
Siemens Healthineers
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories
BioMerieux, Inc.
Nova Biomedical
 
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Flow Cytometry
Microbial and Infectious Diseases
Routine and special chemistry
Hematology
Immunoproteins
Coagulation Test
Others
By End-user:
Emergency rooms
Intensive Care Units
Operating Rooms
Other End Users
 
By Regions:
North America
o U.S.
o Canada
Europe
o UK
o Germany
o ROE
Asia Pacific
o China
o India
o Japan
o ROAPEC
LAMEA
o Brazil
o Mexico
ROW
o Middle East & Africa
 
Furthermore, years considered for the study are as follows:
 
Historical year - 2015, 2016
Base year - 2017
Forecast period - 2018 to 2025
 
Target Audience of the Global Critical Care diagnostics Market in Market Study:
 
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
READ MORE

Scope

TABLE OF CONTENTS

Chapter 1. Global Critical Care diagnostics Market Definition and Scope

1.1. Research Objective

1.2. Market Definition

1.3. Scope of The Study

1.4. Years Considered for The Study

1.5. Currency Conversion Rates

1.6. Report Limitation

Chapter 2. Research Methodology

2.1. Research Process

2.1.1. Data Mining

2.1.2. Analysis

2.1.3. Market Estimation

2.1.4. Validation

2.1.5. Publishing

2.2. Research Assumption

Chapter 3. Executive Summary

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2. Key Trends

Chapter 4. Global Critical Care diagnostics Market Dynamics

4.1. Growth Prospects

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.2. Industry Analysis

4.2.1. Porter's 5 Force Model

4.2.2. PEST Analysis

4.2.3. Value Chain Analysis

4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Critical Care diagnostics Market, By Type

5.1. Market Snapshot

5.2. Market Performance - Potential Model

5.3. Global Critical Care diagnostics Market, Sub Segment Analysis

5.3.1. Flow Cytometry

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2. Hematology

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.3. Routine and special chemistry

5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.4. Microbial and infectious diseases

5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.5. Immunoproteins

5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.6. Coagulation test

5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.7. Others

5.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Critical Care diagnostics Market, By End-user

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Global Critical Care diagnostics Market, Sub Segment Analysis

6.3.1. Emergency Rooms

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2. Operating rooms

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3. Intensive care units

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4. Other End-users

6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Critical Care diagnostics Market, by Regional Analysis

7.1. Critical Care diagnostics Market, Regional Market Snapshot (2015-2025)

7.2. North America Critical Care diagnostics Market Snapshot

7.2.1. U.S.

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2. Canada

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.2.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3. Europe Critical Care diagnostics Market Snapshot

7.3.1. U.K.

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

7.3.2. Germany

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3. Rest of Europe

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4. Asia Critical Care diagnostics Market Snapshot

7.4.1. China

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2. India

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3. Japan

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4. Rest of Asia Pacific

7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

7.5. Latin America Critical Care diagnostics Market Snapshot

7.5.1. Brazil

7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

7.5.2. Mexico

7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.5.2.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6. Rest of The World

7.6.1. Middle East and Africa

7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.6.1.3. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)

 

Chapter 8. Competitive Intelligence

8.1. Company Market Share (Subject to Data Availability)

8.2. Top Market Strategies

8.3. Company Profiles

8.3.1. Abbott Laboratories

8.3.1.1. Overview

8.3.1.2. Financial (Subject to Data Availability)

8.3.1.3. Product Summary

8.3.1.4. Recent Developments

8.3.2. Alere, Inc.

8.3.3. Beckman Coulter, Inc.

8.3.4. Becton Dickinson and Company,

8.3.5. Bayer AG

8.3.6. Siemens Healthineers

8.3.7. F. Hoffmann-La Roche Ltd.

8.3.8. Bio-Rad Laboratories

8.3.9. BioMerieux, Inc.

8.3.10. Nova Biomedical


List Of Figure

FIG 1. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY

FIG 2. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES

FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS

FIG 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, KEY TRENDS 2016

FIG 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2017-2025

FIG 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL

FIG 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, PEST ANALYSIS

FIG 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS

FIG 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 15. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 16. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 17. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 18. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 19. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)

FIG 20. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2015 & 2025

FIG 21. NORTH AMERICA CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 22. EUROPE CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 23. ASIA PACIFIC CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 24. LATIN AMERICA CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 25. ROW CRITICAL CARE DIAGNOSTICS MARKET 2015 & 2025 (USD BILLION)

FIG 26. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)


List Of Table

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CRITICAL CARE DIAGNOSTICS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CRITICAL CARE DIAGNOSTICS MARKET

TABLE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)

TABLE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)

TABLE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2015-2025 (USD BILLION)

TABLE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 15. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 16. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 17. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 18. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 19. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 20. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 21. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 22. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 23. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 24. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 25. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 26. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 27. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 28. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 29. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 30. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 31. U.S. CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 32. U.S CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 33. U.S CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 34. CANADA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 35. CANADA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 36. CANADA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 37. UK CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 38. UK CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 39. UK CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 40. GERMANY CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 41. GERMANY CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 42. GERMANY CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 43. ROE CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 44. ROE CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 45. ROE CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 46. CHINA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 47. CHINA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 48. CHINA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 49. INDIA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 50. INDIA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 51. INDIA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 52. JAPAN CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 53. JAPAN CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 54. JAPAN CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 55. ROAPAC CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 56. ROAPAC CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 57. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 58. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 59. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 60. MEXICO CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 61. MEXICO CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 62. MEXICO CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 63. MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 64. MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 65. MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Abbott Laboratories

Alere, Inc.

Beckman Coulter, Inc.

Becton Dickinson and Company,

Bayer AG

Siemens Healthineers

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories

BioMerieux, Inc.

Nova Biomedical